1.Immunocytochemical localization of myelin basic protein, proteolipid protein and myelin-associated glycoprotein in human oligodendrocyte in culture.
Korean Journal of Anatomy 1991;24(1):86-92
No abstract available.
Humans*
;
Myelin Basic Protein*
;
Myelin Sheath*
;
Myelin-Associated Glycoprotein*
;
Oligodendroglia*
2.Facial Diplegia in Plasmodium vivax Malaria.
Jae Eun SIM ; Young Chul CHOI ; Won Joo KIM
Journal of Clinical Neurology 2010;6(2):102-103
BACKGROUND: Facial diplegia has diverse etiologies, including viral and bacterial infections such as diphtheria, syphilis and Lyme disease, and also protozoal infection in very rarely cases. CASE REPORT: A 20-year-old male patient was admitted to our hospital due to bilateral weakness of the upper and lower facial muscles. Examination revealed that the patient had a facial diplegia of the peripheral type. A peripheral blood smear demonstrated the presence of the asexual trophozoite stage of Plasmodium vivax with ring-form trophozoites, which led to a diagnosis of malaria. A serum work-up revealed increased IgG titers of antibodies to myelin-associated glycoprotein and ganglioside GD1b. The patient was administered antimalarial treatment, 1 week after which he showed signs of recovery. To our knowledge, this is the first case of facial diplegia after malaria infection, providing evidence that the mechanism underlying the condition is related to immune-mediated disease. CONCLUSIONS: Facial diplegia can manifest after P. vivax infection.
Antibodies
;
Bacterial Infections
;
Diphtheria
;
Facial Muscles
;
Humans
;
Immunoglobulin G
;
Lyme Disease
;
Malaria
;
Malaria, Vivax
;
Male
;
Myelin-Associated Glycoprotein
;
Plasmodium
;
Plasmodium vivax
;
Syphilis
;
Trophozoites
;
Young Adult
3.Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice.
Chunyun LIU ; Shangde GUO ; Nianping ZHANG ; Jiezhong YU ; Baoguo XIAO ; Cungen MA
Journal of Central South University(Medical Sciences) 2016;41(3):225-232
OBJECTIVE:
To explore the therapeutic effect of Fasudil-modified splenic mononuclear cells (MNCs) in experimental autoimmune encephalomyelitis (EAE) and the possible mechanisms.
METHODS:
C57BL/6 female mice were immunized with myelin oligodendrocyte glycoprotein peptide 35-55 to establish active immunity EAE model. Splenic MNCs were isolated on the 9th day after immunization and treated with or without Fasudil for 72 h in vitro. These cells were collected for analysis of the variance of T cell subtypes, the level of cytokines and the activity of Rho kinase (ROCK). MNCs (5×107 cells) were resuspended in 500 µL of phosphate buffer solution (PBS) and transferred into EAE model (intraperitoneal injection), which was divided into a PBS-MNCs group and a Fasudil-MNCs group. Changes of body weight and clinical symptom scores were observed.
RESULTS:
Splenic encephalitogenic MNCs from EAE mice on the 9th day after immunization could establish passive transfer EAE model. But Fasudil-treated MNCs did not trigger EAE development. Compared with the PBS-MNCs group, the loss of body weight was less in the Fasudil-MNCs group. The in vitro experiment indicated that Fasudil could suppress the activity of ROCK on MNCs (P<0.01), decrease the percentage of CD4+ T cells with the expression of interferon-γ (IFN-γ) and interleukin-17 (IL-17) (IFN-γ: P<0.01; IL-17: P<0.05), while increase the secretion of CD4+ T cells with the expression of transforming growth factor-β (TGF-β) and IL-10 (all P<0.001) . Furthermore, Fasudil could inhibit the release of IL-17 (P<0.001) and enhance the level of IL-10 (P<0.05).
CONCLUSION
Fasudil-modified cell therapy affects the occurrence and development of EAE by inhibiting the inflammatory reaction of helper T cell 1 (Th1) and Th17 while enhancing the immunoregulative effect of Th2.
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
;
analogs & derivatives
;
Animals
;
Encephalomyelitis, Autoimmune, Experimental
;
Female
;
Interferon-gamma
;
Interleukin-10
;
Interleukin-17
;
Mice
;
Mice, Inbred C57BL
;
Myelin-Oligodendrocyte Glycoprotein
;
Spleen
;
T-Lymphocytes
;
Transforming Growth Factor beta
;
rho-Associated Kinases